Search results
Memantine is a medicine for dementia. It is used to treat memory loss which is one of the main symptoms of dementia. It is also used to treat the symptoms of: Alzheimer's disease; dementia with Lewy bodies; mixed dementia – when you have more than one type of dementia; corticobasal degeneration (CBD) Memantine does not work for everyone.
13 mar 2018 · Memantine (MEM), an antagonist of extrasynaptic NMDAR, is currently used for the treatment of AD jointly with acetylcholinesterase inhibitors.
Memantine for dementia – what, why, who and when? The new dementia NICE guidelines published in June 2018 state that we should consider memantine for patients with moderate Alzheimer’s Disease and offer
2 mar 2007 · Memantine, an NMDA receptor antagonist has been found to be effective, both as monotherapy and in combination with donepezil, in the treatment of patients with moderate to severe stage AD.
6 cze 2023 · Memantine is a noncompetitive moderate‐affinity strong voltage‐dependent N‐methyl‐D‐aspartate receptor antagonist. It has been used to treat Alzheimer's disease (AD) since 1989. In 2018, it became the second most commonly used drug for the treatment of dementia in the world.
Memantine (MEM), an antagonist of extrasynaptic NMDAR, is currently used for the treatment of AD jointly with acetylcholinesterase inhibitors.
Memantine is an NMDA receptor antagonist that—on the basis of studies in animals—is thought to reduce overstimulation of the NMDA receptor (caused by abnormally high concentrations of glutamate) in its resting state and to restore normal receptor‐signalling function.
